Biotech company Acuitas Therapeutics and Germany-based CureVac have settled Acuitas' lawsuit demanding credit for inventions ...
Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants ...
CureVac has accused Pfizer and BioNTech of infringing its patents, including the patents at issue in the Acuitas case, in an ongoing lawsuit in Virginia. The case is Acuitas Therapeutics Inc v.
Kaiser Permanente Entity Reports Breach Of Data For 13 Million: Kaiser Permanente, the Oakland-based health care conglomerate, is warning millions of customers that one of its divisions may have ...
Moderna and CureVac have also issued legal proceedings ... to vigorously defend against these claims.” BioNTech said it was aware of the lawsuit and that it would not comment on “legal ...
GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of the COVID-19 ...
Shortly after winning a stay on a COVID-19 vaccine patent lawsuit brought by Moderna, Pfizer and its German partner BioNTech are being dragged into another round of mRNA litigation by GSK.
GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of the ...
CureVac is asserting its intellectual property rights in litigation against Pfizer/BioNTech in Germany, the U.S. and the UK. In the U.S., a magistrate judge recently granted a motion by Acuitas ...